Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.00 (0.00%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.03m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Placing

14 Oct 2009 07:00

RNS Number : 7162A
Sabien Technology Group PLC
14 October 2009
 



14 October 2009

Sabien Technology Group plc

("Sabien" or "the Company")

GBP1.475 million Placing

Placing of 4,916,000 Ordinary Shares at 30 pence per share to raise  approximately  GBP1.475 million from institutional and other investors

Placing to support the Company's growth and working capital requirements

Funds raised will also allow the Company to repay the TVI 2 Limited ("TVI 2") loan early thereby reducing the number of warrants issued to TVI 2 from 2,952,279 to 1,518,356 and leaving the Company debt free

Sabien, the manufacturer and supplier of M2G, an energy efficiency technology, is pleased to announce that it has conditionally placed 4,916,000 new ordinary shares of 5 pence each (the "Placing Shares") at a price of 30 pence per share (the "Placing Price"), raising approximately GBP1.475 million (before  expenses) for the Company from a number of institutional and other investors (the "Placing") through Arbuthnot Securities.

The funds raised from the Placing will provide Sabien with the capital necessary to support the  Company's working capital requirements and will allow it to continue to grow its prospective pipeline  for the installation of M2G devices, which currently stands at c. 3,000 devices

The Placing Shares have been conditionally placed with institutional and other investors by Arbuthnot Securities Limited. The Placing Shares will, when issued, rank pari passu with the Company's existing issued ordinary shares, and dealings are expected to commence in the Placing Shares on Monday19 October 2009 ("Admission"). 

 

Alan O'Brien, Chief Executive Officer for Sabien said:

"I am very pleased by the support we have received from existing and new shareholders. The funds raised through this placing provide Sabien with the resources to pursue its growth strategy in the European and US markets and to repay its loan to TVI 2 leaving the company completely debt free. Early repayment of the TVI 2 loan means that approximately 50 per cent. of the warrants issued to TVI 2 will be cancelled. I would also like to thank all our advisers for a job well done." 

Total Voting Rights

Following Admission, the total number of issued ordinary shares of 5 pence each in the Company (the "Ordinary Shares") will be 31,486,511. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules. 

For further information:

 Sabien Technology Group plc 

 Alan O'Brien, CEO

Tel: +44 (0) 20 7993 3700

 Gus Orchard, CFO

www.sabien-tech.co.uk

Arbuthnot Securities Limited

 Antonio Bossi

Tel: +44 (0) 20 7012 2000

www.arbuthnotsecurities.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEILFIRITLVLIA
Date   Source Headline
16th Aug 20227:00 amRNSExtension of Sales Agency Agreement
5th Aug 20225:15 pmRNSNotice of GM & Holdings in the Company
4th Aug 20227:00 amRNSOversubscribed Broker Option to raise £100,000
3rd Aug 20227:00 amRNSPlacing to raise £500,000 & Broker Option
8th Jul 202212:45 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update
7th Jun 20227:00 amRNSHolding(s) in Company
13th May 20227:00 amRNSWelsh Freeport
5th May 20227:00 amRNSUpdate on b.grn
11th Apr 20221:00 pmRNSCorporate Update - Contract Win
4th Apr 20225:00 pmRNSProject COFFEE - Replacement
4th Apr 20222:30 pmRNSProject COFFEE
31st Mar 20224:02 pmRNSHalf-year Report
31st Mar 20227:00 amRNSHolding(s) in Company
25th Mar 20227:00 amRNSContract Win
3rd Feb 20222:03 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSMOU signed with Irish Renewable Fuels Ltd.
1st Feb 20222:43 pmRNSLicence agreement with Proton Technologies Canada
18th Jan 20227:00 amRNSChanges to Warrant Terms
14th Jan 20224:25 pmRNSHolding(s) in Company
31st Dec 202112:00 pmRNSTotal Voting Rights
22nd Dec 20217:00 amRNSAgreement for Establishment of SPV
26th Nov 20217:00 amRNSWarrant Exercise
11th Nov 20217:00 amRNSLicence agreement with Proton Technologies
4th Nov 20217:00 amRNSRole of Carbon Credits, Blockchain & Carbon Market
1st Nov 20217:00 amRNSCOP26: Sabien hosts Green Economics Debate
29th Oct 20215:00 pmRNSTotal Voting Rights
14th Oct 20213:00 pmRNSResult of AGM
14th Oct 202110:00 amRNSSabien Presentation at FTE Mykonos
14th Oct 20218:00 amRNSIssue of Equity
14th Oct 20217:30 amRNSAGM Statement
14th Oct 20217:00 amRNSSubscription and possible Co-operation Agreement
21st Sep 20217:00 amRNSHolding(s) in Company
16th Sep 20211:02 pmRNSAeristech: Investor Update
16th Sep 202111:30 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSSales Agency Agreement
14th Sep 20216:00 pmRNSPosting of Annual Report & Notice of AGM
31st Aug 20217:12 amRNSFinal Results for the year to 30 June 2021
31st Aug 20217:00 amRNSFinal Results for the Year to 30 June 2021
10th Aug 202112:12 pmRNSHolding(s) in Company
7th Jul 20217:00 amRNSTrading Update
25th Jun 202111:15 amRNSOperational Update
18th Jun 20217:00 amRNSAppointment of Chief Scientific Officer
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20213:45 pmRNSResult of AGM
25th Mar 20217:00 amRNSHalf-year Report
19th Mar 20218:45 amRNSHolding(s) in Company
11th Mar 20214:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.